Key result
Low serum albumin predicts increased cardiac and bleeding events in CVD, particularly ACS.
Why the study?
Serum albumin level is associated with prognoses in cardiovascular disease, but its role as a residual risk factor and need for reassessment during chronic phases remains to be clarified.
Is serum albumin level associated with the prognosis and prediction of adverse events in patients with cardiovascular disease?
Is serum albumin level associated with the prognosis and prediction of adverse events in patients with cardiovascular disease?
Serum albumin level is a valuable biomarker for risk stratification and predicting both ischemic and bleeding events in patients with cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Supports incorporation into ACS risk models; hypothesis-generating and should not yet change practice.
Yoshioka et al. (2022) conducted a review in Cardiovascular disease. Serum albumin level was evaluated. Low serum albumin level serves as a predictor for adverse cardiac and bleeding events in patients with cardiovascular disease, particularly acute coronary syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: